
Martin Scheringer
Researcher
1
APPEARANCES
1
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
SEP 28
OCT 5
Oct 7, 2026
PFAS in MedTech: What You Need to Do Now (Swiss Medtech special, with Martin Scheringer and Arne Jaksch)
5:14
5:29
5:37
B
5:06Barbara MettlerHOST
Can you explain to us what are PFAS and why is the topic receiving so much attention at the moment?

Martin ScheringerGUEST
PFAS are what we call in chemistry organic chemicals, which means they con- uh, contain a lot of carbon, specifically chains of carbon atoms, and to these carbon atoms, fluorine atoms are bonded.

Martin ScheringerGUEST
So the, the essential element of PFAS is a chain of carbons that carry fluorine.

Martin ScheringerGUEST
The chemical name PFAS stands for per- and polyfluoroalkyl substances, and alkyl means a carbon chain, and per- or polyfluorinated means that there are fluorines bonded to it.
27 MINS LATER
B
32:47Barbara MettlerHOST
How do we avoid then, uh, when we develop or look for alternatives that they are not harmful or also harmful?